Portfolio Company RoosterBio Highlighted in Dynamk’s Recent Annual General Meeting Dynamk Capital November 1, 2021
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis Pharma’s Almanac September 29, 2021
RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium BioInformant May 21, 2021
Rooster Bio and Sartorius Team to Streamline hMSC Production BioProcess International January 22, 2021
RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer October 5, 2021
RoosterBio Releases RoosterGEM™, Cell & Gene Therapy’s First Complete Transduction Medium May 20, 2021
![$image['alt']](https://www.roosterbio.com/wp-content/uploads/2019/09/img-26.jpg)